Alcon Inc. logo

Alcon Inc. (ALC)

Market Open
25 Jul, 18:33
NYSE NYSE
$
91. 64
-0.26
-0.28%
$
43.11B Market Cap
- P/E Ratio
1.06% Div Yield
598,009 Volume
- Eps
$ 91.9
Previous Close
Day Range
90.71 91.71
Year Range
80.48 101.1
Want to track ALC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 25 days

Summary

ALC trading today lower at $91.64, a decrease of 0.28% from yesterday's close, completing a monthly increase of or $91.64. Over the past 12 months, ALC stock gained .
ALC pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next estimated payment will be in In 9 months on May 15, 2026 for a total of $0.3334.
The last earnings report, released on May 08, 2025, missed the consensus estimates by -0.03%. On average, the company has fell short of earnings expectations by -0.08%, based on the last three reports. The next scheduled earnings report is due on Aug 19, 2025.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ALC Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Alcon Stock Gains Following UNITY VCS' Approval in Canada

Alcon Stock Gains Following UNITY VCS' Approval in Canada

ALC's UNITY VCS gets Canada's approval, advancing surgical precision with faster, more efficient technology.

Zacks | 2 weeks ago
Is it Apt to Retain Alcon Stock in Your Portfolio for Now?

Is it Apt to Retain Alcon Stock in Your Portfolio for Now?

ALC stays on investors' radar due to its Vision Care arm's performance and contributions from new products despite macro risks and stiff competition.

Zacks | 3 weeks ago
Alcon Stock Rises Following the FDA Approval of TRYPTYR

Alcon Stock Rises Following the FDA Approval of TRYPTYR

FDA approves ALC's TRYPTYR, a new dry eye treatment with rapid tear production. The approval is supported by strong Phase 3 trial results.

Zacks | 1 month ago

Alcon Inc. Dividends

Alcon Inc. logo
ALC In 9 months
Estimated
Annual
$0.33 Per Share
Alcon Inc. logo
ALC 2 months ago
Paid
Annual
$0.33 Per Share
Alcon Inc. logo
ALC 14 May 2024
Paid
Annual
$0.26 Per Share
Alcon Inc. logo
ALC 10 May 2023
Paid
Annual
$0.24 Per Share
Alcon Inc. logo
ALC 3 May 2022
Paid
Annual
$0.2 Per Share
Alcon Inc. logo
ALC 4 May 2021
Paid
Annual
$0.11 Per Share

Alcon Inc. Earnings

20 Aug 2025 (In 3 weeks) Date
0.72
Cons. EPS
-
EPS
19 Aug 2025 (In 3 weeks) Date
0.71
Cons. EPS
-
EPS
8 May 2025 Date
0.76
Cons. EPS
0.73
EPS
25 Feb 2025 Date
0.72
Cons. EPS
0.72
EPS
12 Nov 2024 Date
0.74
Cons. EPS
0.53
EPS
Alcon Inc. logo
ALC In 9 months
Estimated
Annual
$0.33 Per Share
Alcon Inc. logo
ALC 2 months ago
Paid
Annual
$0.33 Per Share
Alcon Inc. logo
ALC 14 May 2024
Paid
Annual
$0.26 Per Share
Alcon Inc. logo
ALC 10 May 2023
Paid
Annual
$0.24 Per Share
Alcon Inc. logo
ALC 3 May 2022
Paid
Annual
$0.2 Per Share
Alcon Inc. logo
ALC 4 May 2021
Paid
Annual
$0.11 Per Share
20 Aug 2025 (In 3 weeks) Date
0.72
Cons. EPS
-
EPS
19 Aug 2025 (In 3 weeks) Date
0.71
Cons. EPS
-
EPS
8 May 2025 Date
0.76
Cons. EPS
0.73
EPS
25 Feb 2025 Date
0.72
Cons. EPS
0.72
EPS
12 Nov 2024 Date
0.74
Cons. EPS
0.53
EPS

Alcon Inc. (ALC) FAQ

What is the stock price today?

The current price is $91.64.

On which exchange is it traded?

Alcon Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is ALC.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.06%.

What is its market cap?

As of today, the market cap is 43.11B.

What is the earnings per share?

The EPS is 0.71.

When is the next earnings date?

The next earnings report will release on Aug 19, 2025.

Has Alcon Inc. ever had a stock split?

No, there has never been a stock split.

Alcon Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
David J. Endicott CEO
NYSE Exchange
H01301128 Cusip
CH Country
25,599 Employees
14 May 2025 Last Dividend
- Last Split
- IPO Date

Overview

Alcon Inc. is a global leader in eye care, specializing in the research, development, manufacturing, distribution, and sales of a wide range of eye care products. Catering to both eye care professionals and patients, Alcon's mission is to enhance vision and improve people's lives through innovative products and solutions. The company's portfolio spans across surgical procedures and vision care, addressing a broad spectrum of eye health needs. Originally founded in 1945 as Alcon Universal S.A., the company underwent a name change to Alcon Inc. in December 2001 and has since established its headquarters in Geneva, Switzerland, marking its presence as a key player in the eye care industry on a global scale.

Products and Services

Alcon Inc.'s offerings are divided into two main segments: Surgical and Vision Care, each catering to distinct aspects of eye health and surgery.

  • Surgical Segment:
  • Within the surgical field, Alcon provides a comprehensive array of products including equipment, instrumentation, diagnostics, intraocular lenses (IOLs), and other implantables, along with various consumables. These specialized products support a wide range of procedures from cataract surgery to vitreoretinal operations. Notable products within this segment include the Centurion Vision System, LenSx Laser System for cataract treatment, Constellation Vision Systems for vitreoretinal surgeries, and the WaveLight Lasers for LASIK treatments. Additionally, Alcon offers innovative solutions like the NGENUITY 3D Visualization System and the ORA system for enhanced surgical precision and outcomes. Custom surgical packs and a variety of manual surgical instruments further complement Alcon’s surgical offerings.

  • Vision Care Segment:
  • Alcon’s Vision Care segment focuses on enhancing daily eye health and visual comfort through a wide range of products. This includes daily disposable, reusable, and color-enhancing contact lenses designed to meet diverse needs and preferences. Beyond corrective lenses, Alcon provides solutions for common eye concerns such as dry eye, ocular allergies, and glaucoma, as well as products for contact lens care. The segment is also home to ocular vitamins and redness relievers, aimed at maintaining overall eye health and comfort.

Contact Information

Address: Chemin de Blandonnet 8
Phone: 41 58 911 20 00